Page last updated: 2024-09-02

fingolimod hydrochloride and Body Weight

fingolimod hydrochloride has been researched along with Body Weight in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.76)18.2507
2000's14 (66.67)29.6817
2010's6 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lv, L; Qian, J; Ye, S; Ye, Y; Zhu, C1
Armida, M; De Simone, R; Mazziotti, V; Minghetti, L; Pèzzola, A; Popoli, P; Potenza, RL1
Bidadkosh, A; Buikema, H; Deelman, LE; Hamidi Shishavan, M; Henning, RH; Lambooy, S; van den Born, J; Yazdani, S1
Dikow, R; Gross, ML; Hug, F; Schaier, M; Sommerer, C; Vorwalder, S; Waldherr, R; Zeier, M1
Bergonzini, V; Costa, S; Galletti, M; Nofer, JR; Pignatti, E; Poti, F; Simoni, M; Weber, C1
Chen, X; Li, J; Lu, Y; Wan, H; Ye, S; Zhang, S; Zheng, G; Zhu, H1
Choi, J; Chon, J; In, J; Joo, J; Kim, D; Lee, H; Moon, H; Park, J1
Gottschalk, R; Maki, T; Monaco, AP1
Kawachi, H; Krämer, S; Martini, S; Neumayer, HH; Peters, H; Shimizu, F; Wang, Y1
Itoh, M; Kataoka, H; Kuno, A; Nakao, H; Ogawa, K; Ohara, H; Okamoto, T; Sano, H; Shirai, T; Tang, M; Yamada, T1
Chan, FL; Chua, CW; Ho, J; Lee, DT; Ling, MT; Man, K; Wang, X; Wong, YC; Zhou, C1
Ito, T; Matsuda, C; Matsuda, H; Miao, G; Nishida, T; Nozawa, M; Sawa, Y; Song, J; Tanemura, M1
Bueno, V; Burdmann, EA; Cury, PM; Silva, FR; Silva, LB1
Budde, K; Daig, U; Krämer, S; Loof, T; Martini, S; Neumayer, HH; Peters, H; Wang-Rosenke, Y1
Balatoni, B; Foster, CA; Hiestand, PC; Koziel, A; Lambrou, GN; Schönborn, V; Storch, MK; Swoboda, EM; Weissert, R1
Fauser, U; Schluesener, HJ; Zhang, Z; Zhang, ZY1
Fujimura, A; Hozumi, Y; Kobayashi, E; Miyata, M1
Hikita, N; Ikeda, E; Kurose, S; Mochizuki, M; Tokiwa, M1
Isobe, M; Kitabayashi, H; Sekiguchi, M; Suzuki, J; Watanabe, N; Yazaki, Y1
Baumlin, Y; Hof, A; Hof, RP; Nikolova, Z2

Other Studies

21 other study(ies) available for fingolimod hydrochloride and Body Weight

ArticleYear
FTY720 attenuates paraquat-induced lung injury in mice.
    International immunopharmacology, 2014, Volume: 21, Issue:2

    Topics: Actins; Acute Lung Injury; Animals; Body Weight; Bronchoalveolar Lavage Fluid; Collagen Type I; Collagen Type III; Disease Models, Animal; Fingolimod Hydrochloride; Interleukin-1beta; Interleukin-6; Lung; Lung Injury; Mice; Mice, Inbred C57BL; Paraquat; Propylene Glycols; Pulmonary Edema; Pulmonary Fibrosis; Sphingosine; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A

2014
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2016, Volume: 13, Issue:4

    Topics: Amyotrophic Lateral Sclerosis; Animals; Body Weight; Brain; Cytokines; Disease Models, Animal; Fingolimod Hydrochloride; Forkhead Transcription Factors; Gene Expression Regulation; Humans; Immunosuppressive Agents; Mice; Mice, Inbred C57BL; Mice, Transgenic; Movement Disorders; Mutation; Nitric Oxide Synthase Type II; Spinal Cord; Superoxide Dismutase

2016
Differential Effects of Long Term FTY720 Treatment on Endothelial versus Smooth Muscle Cell Signaling to S1P in Rat Mesenteric Arteries.
    PloS one, 2016, Volume: 11, Issue:9

    Topics: Animals; Body Weight; Endothelial Cells; Fingolimod Hydrochloride; Gene Expression Regulation; Hemodynamics; Humans; Lysophospholipids; Male; Mesenteric Arteries; Muscle Development; Myocytes, Smooth Muscle; Pressure; Rats; Rats, Wistar; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Time Factors; Vasoconstriction

2016
Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats.
    American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:3

    Topics: Administration, Oral; Albuminuria; Animals; Blood Pressure; Body Weight; Chemokine CCL2; Chemokine CCL5; Chemokines; Creatinine; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Fibronectins; Fibrosis; Fingolimod Hydrochloride; Gene Expression Regulation; Immunosuppressive Agents; Inflammation Mediators; Kidney; Kidney Failure, Chronic; Lymphocytes; Macrophages; Male; Nephrectomy; Nephritis; Phenotype; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, CCR1; Receptors, CCR2; Receptors, CCR5; Sphingosine; Time Factors; Transforming Growth Factor beta1

2009
Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
    Vascular pharmacology, 2012, Aug-19, Volume: 57, Issue:1

    Topics: Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Atherosclerosis; Body Weight; CD11b Antigen; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Fingolimod Hydrochloride; Genes, MHC Class II; Indans; Interleukin-2; Interleukin-6; Lymph Nodes; Lymphocyte Activation; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Oxadiazoles; Proprotein Convertases; Propylene Glycols; Receptors, LDL; Receptors, Lysosphingolipid; Serine Endopeptidases; Sphingosine; Spleen

2012
Effect of FTY720 on some physiological indexes of Non-Obese Diabetic (NOD) Mice.
    International journal of molecular sciences, 2012, Volume: 13, Issue:5

    Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Fingolimod Hydrochloride; Glutamate Decarboxylase; Immunosuppressive Agents; Kidney; Liver; Mice; Mice, Inbred NOD; Propylene Glycols; Sphingosine; Spleen

2012
FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
    Diabetes/metabolism research and reviews, 2013, Volume: 29, Issue:1

    Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Cell Survival; Diabetes Mellitus, Type 2; Female; Fingolimod Hydrochloride; Glucose Tolerance Test; Immunosuppressive Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Mice; Propylene Glycols; Sphingosine

2013
Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice.
    Transplantation, 2002, Dec-27, Volume: 74, Issue:12

    Topics: Animals; Body Weight; Cyclophosphamide; Diabetes Mellitus, Type 1; Female; Fingolimod Hydrochloride; Graft Rejection; Immunosuppressive Agents; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Propylene Glycols; Sphingosine

2002
Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
    Kidney international, 2004, Volume: 66, Issue:4

    Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Creatinine; Extracellular Matrix; Fibrosis; Fingolimod Hydrochloride; Glomerulosclerosis, Focal Segmental; Heart Rate; Immunosuppressive Agents; Isoantibodies; Lymphocyte Count; Lymphocytes; Male; Propylene Glycols; Proteinuria; Rats; Rats, Wistar; Sphingosine

2004
FTY720, an immunosuppressant, attenuates chronic pancreatitis in rats by suppressing T-cell infiltration.
    Pancreas, 2005, Volume: 30, Issue:3

    Topics: Animals; Body Weight; Fingolimod Hydrochloride; Hydroxyproline; Immunosuppressive Agents; Interferon-gamma; Male; Organ Size; Pancreas; Pancreatitis, Chronic; Peroxidase; Propylene Glycols; Rats; Rats, Wistar; RNA, Messenger; Sphingosine; T-Lymphocytes; Transforming Growth Factor beta; Transforming Growth Factor beta1

2005
FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer.
    International journal of cancer, 2005, Dec-20, Volume: 117, Issue:6

    Topics: Androgens; Animals; Apoptosis; beta Catenin; Body Weight; Cadherins; Caspase 3; Caspases; Cell Division; Fingolimod Hydrochloride; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Orchiectomy; Platelet Endothelial Cell Adhesion Molecule-1; Propylene Glycols; Prostate-Specific Antigen; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Sphingosine; Vascular Endothelial Growth Factor A

2005
Inhibition of donor-derived T cells trafficking into target organs by FTY720 during acute graft-versus-host disease in small bowel transplantation.
    Clinical and experimental immunology, 2006, Volume: 146, Issue:1

    Topics: Acute Disease; Animals; Body Weight; Cytokines; Fingolimod Hydrochloride; Graft vs Host Disease; Immunosuppressive Agents; Intestine, Small; Liver; Lymphocyte Count; Male; Propylene Glycols; Rats; Rats, Inbred WF; Skin; Sphingosine; T-Lymphocyte Subsets; Transplantation Chimera

2006
FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    International immunopharmacology, 2006, Dec-20, Volume: 6, Issue:13-14

    Topics: Animals; Body Weight; Cell Count; Creatinine; Cyclosporine; Drug Therapy, Combination; Fingolimod Hydrochloride; Graft Survival; Histocompatibility Antigens Class II; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Kidney; Lymph Nodes; Lymphocyte Count; Lymphocytes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Potassium; Propylene Glycols; Skin Transplantation; Sodium; Sphingosine; Spleen; Transplantation, Homologous

2006
S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
    American journal of physiology. Renal physiology, 2007, Volume: 292, Issue:6

    Topics: Animals; Antibodies, Blocking; Blood Pressure; Body Weight; Collagen Type III; Extracellular Matrix; Fibronectins; Fingolimod Hydrochloride; Glomerulonephritis, Membranoproliferative; Heart Rate; Immunohistochemistry; Kidney Glomerulus; Leukocyte Count; Lipopolysaccharides; Male; Nitric Oxide Synthase Type II; Plasminogen Activator Inhibitor 1; Propylene Glycols; Proteinuria; Rats; Rats, Wistar; Receptors, Lysosphingolipid; Sphingosine; Thy-1 Antigens; Transforming Growth Factor beta

2007
FTY720 sustains and restores neuronal function in the DA rat model of MOG-induced experimental autoimmune encephalomyelitis.
    Brain research bulletin, 2007, Oct-19, Volume: 74, Issue:5

    Topics: Analysis of Variance; Animals; Body Weight; Disease Models, Animal; Electric Stimulation; Encephalomyelitis, Autoimmune, Experimental; Evoked Potentials, Somatosensory; Evoked Potentials, Visual; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Longitudinal Studies; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Neural Conduction; Propylene Glycols; Rats; Reaction Time; Sphingosine; Spinal Cord; Time Factors

2007
FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves.
    Experimental neurology, 2008, Volume: 210, Issue:2

    Topics: Animals; Body Weight; CD3 Complex; Disease Models, Animal; Ectodysplasins; Fingolimod Hydrochloride; Flow Cytometry; Immunosuppressive Agents; Lymphocytes; Macrophages; Male; Neuritis, Autoimmune, Experimental; Propylene Glycols; Rats; Rats, Inbred Lew; Sciatic Nerve; Sphingosine; Sulfonamides

2008
Immunotherapy for experimental rat autoimmune thyroiditis using a novel immunosuppressant, FTY720.
    Life sciences, 1999, Volume: 65, Issue:17

    Topics: Animals; Body Weight; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Liver; Organ Size; Propylene Glycols; Rats; Sphingosine; Spleen; Thyroid Gland; Thyroiditis, Autoimmune; Thyrotropin

1999
Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats.
    Experimental eye research, 2000, Volume: 70, Issue:1

    Topics: Animals; Antibodies; Arrestin; Autoimmune Diseases; Blood Cell Count; Body Weight; Chi-Square Distribution; Dose-Response Relationship, Drug; Fingolimod Hydrochloride; Immunosuppressive Agents; Male; Propylene Glycols; Rats; Rats, Inbred Lew; Retinitis; Sphingosine; Statistics, Nonparametric; T-Lymphocytes; Uveitis

2000
FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:3

    Topics: Analysis of Variance; Animals; Autoimmune Diseases; Body Weight; Fingolimod Hydrochloride; Immunosuppressive Agents; Injections, Intraperitoneal; Lymphocyte Count; Lymphocytes; Male; Myocarditis; Organ Size; Propylene Glycols; Rats; Rats, Inbred Lew; Sphingosine; Tacrolimus

2000
The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD.
    Transplant immunology, 2000, Volume: 8, Issue:2

    Topics: Animals; Body Weight; Drug Therapy, Combination; Everolimus; Fingolimod Hydrochloride; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Lymphocyte Count; Male; Myocardium; Propylene Glycols; Rats; Rats, Inbred Lew; Sirolimus; Sphingosine; Transplantation, Heterotopic

2000
Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models.
    Transplant immunology, 2001, Volume: 8, Issue:4

    Topics: Adjuvants, Immunologic; Animals; Body Weight; Cyclosporine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Fingolimod Hydrochloride; Graft Rejection; Graft Survival; Heart Transplantation; Histocompatibility Antigens; Immunosuppressive Agents; Lymphocyte Count; Male; Models, Animal; Propylene Glycols; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Skin Transplantation; Sphingosine

2001